Employee Health Trends 2020 Report Reveals Key Trends in Mental Health and Opioid Abuse

INDIANAPOLIS, Jan. 23, 2020 /PRNewswire/ — Springbuk, a health intelligence software company, today released its Employee Health Trends 2020 report, revealing emergent employee health trends to help organizations prepare for 2020 health benefits strategies.

Among the key findings, based on Springbuk’s Health Intelligence platform of over 2,500 organizations, the data reveals that nearly 1 in 5 people (19%) have a mental health condition. The average monthly costs of medical and prescription claims for these members is more than twice that of those without a mental health condition. The data also shows that 3.3% of employees are at high risk for opioid abuse, with those who work in government, construction, not-for-profit/religious organizations, and healthcare/wellness organizations even more likely to be at risk.

“Understanding health trends data on this scale can help employers optimize their investments in benefits and improve employee health and the employee experience,” Springbuk co-founder Phil Daniels said. “By zooming out and looking at the whole person, employers can adapt their benefits strategies to accommodate holistic, preventive healthcare.”

The Employee Health Trends 2020 report also revealed some other key insights, including:

  • Members with a mental health condition are two times more likely to classify as a “high-cost claimant” — a member with at least $50,000 in claims
  • 69% of employees with a mental health condition also have a chronic condition
  • Some chronic conditions, such as orthopedic and gastrointestinal issues, can lead to a higher risk of opioid abuse (6x more likely for those with one of these conditions)

Springbuk recommends that employers understand how their organizations compare against benchmarking data to get a comprehensive understanding of their employee health needs to design proactive, effective benefits plans.

About Springbuk

Springbuk is a health intelligence platform empowering everyone in an employer’s health ecosystem through actionable insights to improve their population’s well-being and contain claims costs. Its platform is leveraged by employers, insurance brokers, on-site clinics, third-party administrators, and wellness vendors to identify avoidable medical and prescription spend. These insights allow every stakeholder to make smarter decisions regarding the health of their employee populations. As healthcare costs are rising, Springbuk is working with employers across the country to fight back. Learn more at www.springbuk.com.

View original content:http://www.prnewswire.com/news-releases/employee-health-trends-2020-report-reveals-key-trends-in-mental-health-and-opioid-abuse-300989385.html

SOURCE Springbuk

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

2 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

16 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

17 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

17 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

18 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

20 hours ago